Kimberly Keegan , NP-C
Nurse Practitioner • Wethersfield, CT
1260 Silas Deane Hwy
Wethersfield, CT 061094362
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Kimberly Keegan is listed in NPPES under Nurse Practitioner.
-
NPI assigned on December 13, 2017; this date does not establish years in practice.
-
Published CMS data list 1,221 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- Q5106 — Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units: 530 service units.
- 99213 — Established patient outpatient office visit: 193 service units.
- 99214 — Established patient outpatient office visit: 146 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 368 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Anastrozole — 42 prescription fills, including refills.
- Hydroxyurea — 37 prescription fills, including refills.
- Eliquis (Apixaban) — 29 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 17 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Nurse Practitioner in Connecticut (2024, 367 clinicians with data). Median for this group: 223. Middle half: 84 to 516.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 372 in 2020 to 1,221 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1260 Silas Deane Hwy
Wethersfield, CT 061094362
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Starling Physicians, Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2017
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
308 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $44,768 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $32,986 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
681 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$634,633 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,094.11 across 47 records.
By nature of payment
- Food and Beverage: $995.11 across 46 records.
- Education: $99.00 across 1 record.
Reporting-company totals (3 largest of 21)
- Pfizer Inc.: $125.29 across 8 records.
- Rigel Pharmaceuticals, Inc.: $109.70 across 4 records.
- Pfizer Inc.: $99.00 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
9 years (graduated 2017)
CMS Doctors and Clinicians data list 2017 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Kimberly Keegan has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Kimberly Keegan as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Wethersfield and Connecticut
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Nurse Practitioner in Connecticut (2024, 367 clinicians with data). Median for this group: 223. Middle half: 84 to 516.
Too few clinicians listed under Nurse Practitioner in Wethersfield have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Nurse Practitioner in Connecticut (2024, 367 clinicians with data). Median for this group: $18,379. Middle half: $7,683 to $37,900.
Too few clinicians listed under Nurse Practitioner in Wethersfield have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 75% of clinicians listed under Nurse Practitioner in Connecticut (2024, 367 clinicians with data). Median for this group: $13,944. Middle half: $5,432 to $27,913.
Too few clinicians listed under Nurse Practitioner in Wethersfield have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Nurse Practitioner in Connecticut (2024, 410 clinicians with data). Median for this group: 395. Middle half: 90 to 1,370.
Too few clinicians listed under Nurse Practitioner in Wethersfield have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Connecticut (2024, 410 clinicians with data). Median for this group: $34,638. Middle half: $1,692 to $202,373.
Too few clinicians listed under Nurse Practitioner in Wethersfield have Medicare Part D data for 2024 to compare.
11 active clinicians are listed under Nurse Practitioner with a practice address in Wethersfield, CT (922 in Connecticut).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Wethersfield
45.5% of these 11 clinicians have the CMS telehealth indicator.
63.6% of these 11 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 228% from 372 in 2020 to 1,221 in 2024.
- 2020: 372
- 2021: 394
- 2022: 937
- 2023: 341
- 2024: 1,221
-
Medicare-allowed amount
Medicare-allowed amount increased 57% from $28,434 in 2020 to $44,768 in 2024.
- 2020: $28,434
- 2021: $31,345
- 2022: $33,898
- 2023: $28,935
- 2024: $44,768
-
Paid by Medicare
Paid by Medicare increased 50% from $21,935 in 2020 to $32,986 in 2024.
- 2020: $21,935
- 2021: $24,565
- 2022: $24,402
- 2023: $21,967
- 2024: $32,986
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 397% from 74 in 2020 to 368 in 2024.
- 2020: 74
- 2021: 158
- 2022: 251
- 2023: 377
- 2024: 368
-
30-day fills
30-day fills increased 692% from 86 in 2020 to 681 in 2024.
- 2020: 86
- 2021: 234
- 2022: 471
- 2023: 683
- 2024: 681
-
Part D drug cost
Part D drug cost increased 38708% from $1,635 in 2020 to $634,633 in 2024.
- 2020: $1,635
- 2021: $236,102
- 2022: $792,243
- 2023: $664,943
- 2024: $634,633
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $692.13 in 2021 to $1,094.11 in 2025.
- 2021: $692.13
- 2022: $1,014.06
- 2023: $2,188.80
- 2024: $1,972.77
- 2025: $1,094.11
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 47 records totaling $1,094.11.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Pfizer Inc. |
Education
In-kind items and services
|
— | General | $99.00 |
| Exelixis Inc. |
Food and Beverage
In-kind items and services
|
CABOMETYX | General | $33.04 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
ELIQUIS | General | $30.84 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $30.50 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Itovebi | General | $30.11 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
OPDIVO | General | $28.75 |
| Rigel Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
TAVALISSE | General | $28.65 |
| Rigel Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
TAVALISSE | General | $27.80 |
| Rigel Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
TAVALISSE | General | $27.36 |
| TAIHO ONCOLOGY, INC. |
Food and Beverage
In-kind items and services
|
LONSURF | General | $27.32 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $27.00 |
| Exelixis Inc. |
Food and Beverage
In-kind items and services
|
CABOMETYX | General | $26.20 |
| Rigel Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
TAVALISSE | General | $25.89 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
REBLOZYL | General | $24.61 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $24.60 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $24.54 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
IMBRUVICA | General | $24.27 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $23.82 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
SARCLISA | General | $22.90 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
SARCLISA | General | $22.90 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LORBRENA | General | $22.89 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $22.56 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $22.23 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LORBRENA | General | $22.10 |
| SOBI, INC |
Food and Beverage
In-kind items and services
|
Vonjo | General | $21.82 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2017–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2018–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
Q5106
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
|
530 | 12 | $12.00 | $7.33 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
193 | 158 | $136.00 | $80.40 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
146 | 82 | $202.00 | $113.46 |
|
96372
Injection of drug or substance under skin or into muscle
|
126 | 67 | $63.00 | $12.75 |
|
J3489
Injection, zoledronic acid, 1 mg
|
63 | 13 | $27.00 | $6.16 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
49 | 36 | $225.00 | $56.80 |
|
J3420
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
|
29 | 22 | $3.00 | $1.18 |
|
96523
Irrigation of implanted venous access drug delivery device
|
26 | 17 | $120.00 | $22.70 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
24 | 14 | $478.00 | $117.31 |
|
96366
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
|
21 | 13 | $70.00 | $18.21 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
14 | 14 | $44.00 | $14.31 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Anastrozole | Anastrozole | 42 | 3,420 | $588.58 | 15 |
| Hydroxyurea | Hydroxyurea | 37 | 2,861 | $900.45 | 15 |
| Eliquis | Apixaban | 29 | 1,124 | $22,275.04 | — |
| Dexamethasone | Dexamethasone | 28 | 857 | $551.64 | 17 |
| Acyclovir | Acyclovir | 25 | 1,620 | $355.45 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 1,612 | $195.14 | 11 |
| Gabapentin | Gabapentin | 22 | 990 | $315.37 | — |
| Lenalidomide | Lenalidomide | 21 | 567 | $281,679.36 | 13 |
| Letrozole | Letrozole | 18 | 1,252 | $488.57 | — |
| Ondansetron Hcl | Ondansetron Hcl | 18 | 193 | $148.60 | 14 |
| Revlimid | Lenalidomide | 18 | 490 | $326,458.37 | — |
| Omeprazole | Omeprazole | 17 | 990 | $220.67 | — |
| Prednisone | Prednisone | 15 | 789 | $85.38 | — |
| Oxycodone Hcl | Oxycodone Hcl | 15 | 242 | $165.59 | 13 |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | 990 | $80.38 | — |
| Levofloxacin | Levofloxacin | 13 | 367 | $81.58 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 12 | 917 | $42.85 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20180223001773
CT
1355602822
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Starling Physicians, Pllc
1260 Silas Deane Hwy, Wethersfield, CT 061094362
Phone: 8608324666
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Obstetrics & Gynecology
Women's Health Nurse Practitioner (Board Certified)
Nurse Practitioner - Primary Care
Physician Assistant - Medical
Physician Assistant (Certified)
Career & Practice History
NPI enumerated December 13, 2017.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2018 to August 2026.
NPI Administrative Meta
Other Nurse Practitioners in Wethersfield
- Nina Grabon, AGACNP-BC
- Leah Cipollone, FNP
- Patrice Horan, NP
- Renee Kane
- Meghan Burgess, APRN
- Lani Ralston, ANP
More public profiles in Connecticut
Directory navigation, in NPI number order.
- Lora Small, LCSW Social Worker - Clinical · Hamden
- Ryan Ku Dentist · West Haven
- Daniel Tuohey, PA-C Physician Assistant · Bristol
- Uchenna Okereke, MD Internal Medicine - Infectious Disease · Norwich
- Jason Ptak, PA-C Physician Assistant - Medical · Hartford
- Megan Strong Physician Assistant - Surgical · Bridgeport
- Eric Sussman, MD Neurological Surgery · Hartford
- Craig Sauer, MD Obstetrics & Gynecology · Branford
- Letitia Coleman, FNP Nurse Practitioner - Psychiatric/Mental Health · Trumbull
- Alfonzo Armstead, PA-C Physician Assistant - Medical · Hartford
- Randall Owen, PA-C Physician Assistant - Surgical · Hamden
- Kirk Blais Internal Medicine · Manchester
Mailing Address
2110 Silas Deane Highway
Wethersfield, CT 06109
Phone: 8602583480